Edward Mills of the University of Ottawa, Canada and colleagues argue in this week’s PLoS Medicine that the HIV/AIDS response in Africa needs a more balanced approach to gender, so that both men and women are involved in HIV treatment and prevention…
No Comments »
Filed under: Men's Health
AllAfrica.com examines efforts by African researchers to develop a female-controlled HIV prevention method, writing, “Scientists searching for a gel or vaccine that can prevent HIV infection ride a rollercoaster of hope and disappointment.” The article profiles efforts by researchers from the Centre for the AIDS Program of Research in South Africa (Caprisa) to find a [...]
No Comments »
Filed under: Pharmacy News
During a webinar Thursday hosted by the Health Global Access Project, AVAC, and amfAR, John Blandford, chief of CDC’s Division of Global HIV/AIDS Health Economics, Systems and Integration Branch, presented findings showing “that scaling up antiretroviral therapy (ART) for HIV/AIDS treatment and prevention in the developing world not only saves lives, but saves money too,” [...]
No Comments »
Filed under: Pharmacy News
“Eighty-six percent of HIV-positive people in the Democratic Republic of Congo [DRC] have no access to antiretrovirals, medical charity Doctors Without Borders said Wednesday,” calling the “conditions of access to care for people living with HIV/AIDS … catastrophic,” Agence France-Presse reports.
No Comments »
Filed under: Pharmacy News
Gilead Sciences, Inc. today announced the initiation of a Phase 2 clinical trial evaluating GS-7340 for the treatment of HIV-1 infection in treatment-naïve adults. GS-7340 is a novel prodrug of tenofovir, the active agent in Viread.
No Comments »
Filed under: Pharmacy News
“Thirty years after AIDS made its deadly debut, a future without the disease is finally within reach,” a Boston Globe editorial states, adding, “But just as science is on the verge of winning the battle, financial resources and political will are flagging.”
No Comments »
Filed under: Pharmacy News
Research conducted by NewYork-Presbyterian Hospital/Weill Cornell Medical Center global health investigators and cancer specialists in New York, Qatar and Haiti suggests that aspirin should be evaluated for its ability to prevent development of cervical cancer in HIV-infected women…
No Comments »
Filed under: Women's Health
Research conducted by NewYork-Presbyterian Hospital/Weill Cornell Medical Center global health investigators and cancer specialists in New York, Qatar and Haiti suggests that aspirin should be evaluated for its ability to prevent development of cervical cancer in HIV-infected women.
No Comments »
Filed under: Pharmacy News
(MedPage Today) — HIV-1 viral load in the blood is one of the most important factors influencing transmission to the partner in serodiscordant African couples, according to the results of a recent study.
No Comments »
Filed under: General Health News
For children and adolescents with HIV infection, the recent Food and Drug Administration (FDA) approval of the use of raltegravir, an antiretroviral drug that slows the spread of HIV infection, offers a new weapon to treat HIV infection in children.
No Comments »
Filed under: Pharmacy News
